首页 > 市场调查报告书 > 製药

疼痛

偏头痛治疗药的全球市场 - 市场占有率、规模、趋势、产业分析:各产品类型，各治疗等级，各给药途径，各最终用途，各地区，市场区隔预测(2022年～2030年)

市场调查报告书

商品编码

1150079

偏头痛治疗药的全球市场 - 市场占有率、规模、趋势、产业分析:各产品类型，各治疗等级，各给药途径，各最终用途，各地区，市场区隔预测(2022年～2030年)

Migraine Drugs Market Share, Size, Trends, Industry Analysis Report, By Product Type (Acute/Abortive Treatment, Preventive/Prophylactic Treatment); By Therapeutic Class; By Route of Administration; By End-Use; By Region; Segment Forecast, 2022 - 2030

出版日期: 2022年10月01日 | 出版商:

Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球偏头痛治疗药的市场规模，预计至2030年达到87亿9,000万美元。

本报告提供全球偏头痛治疗药市场调查，市场概要，市场规模和预测，趋势，促进因素、阻碍因素，各产品类型、各治疗等级、各给药途径、各最终用途、各地区等的分析，再加上企业简介等资讯。

偏头痛治疗药 - 产业的概述
偏头痛治疗药市场动态
- 促进因素和机会
- 阻碍因素与课题
波特的五力分析
- 供给企业谈判力
- 新加入厂商的威胁
- 买方议价能力
- 替代品的威胁
- 现有企业间的竞争力
大环境分析
偏头痛治疗药产业趋势
价值链分析
COVID-19影响分析

第5章全球偏头痛治疗药市场:各产品类型

主要调查结果
简介
- 全球偏头痛治疗药市场，各产品类型(2018年～2030年)
急性治疗药/挫折药
- 全球偏头痛治疗药市场，急性治疗药/挫折药，各地区(2018年～2030年)
预防药/预防治疗药
- 全球偏头痛治疗药市场，预防药/预防治疗药物，各地区(2018年～2030年)

第6章全球偏头痛治疗药市场:各治疗等级

主要调查结果
简介
- 全球偏头痛治疗药市场，治疗等级(2018年～2030年)
Triptans
- 全球偏头痛治疗药市场，Triptans，各地区(2018年～2030年)
乙酰胆碱抑制剂/神经毒
- 全球偏头痛治疗药市场，乙酰胆碱抑制剂/神经毒，各地区(2018年～2030年)
麦角生物碱
- 全球偏头痛治疗药市场，麦角生物碱，各地区(2018年～2030年)
NSAID
- 全球偏头痛治疗药市场，NSAID，各地区(2018年～2030年)
Ditans
- 全球偏头痛治疗药市场，Ditans，各地区(2018年～2030年)
CGRP低分子拮抗剂
- 全球偏头痛治疗药市场，CGRP低分子拮抗剂，各地区(2018年～2030年)
CGRP单株抗体
- 全球偏头痛治疗药市场，CGRP单株抗体，各地区(2018年～2030年)
其他
- 全球偏头痛治疗药市场，其他，各地区(2018年～2030年)

第7章全球偏头痛治疗药市场:各给药途径

主要调查结果
简介
- 全球偏头痛治疗药市场，各给药途径(2018年～2030年)
口服
- 全球偏头痛治疗药市场，口服，各地区(2018年～2030年)
注射
- 全球偏头痛治疗药市场，注射，各地区(2018年～2030年)
其他
- 全球偏头痛治疗药市场，其他，各地区(2018年～2030年)

第8章全球偏头痛治疗药市场:各最终用途

主要调查结果
简介
- 全球偏头痛治疗药市场，各最终用途(2018年～2030年)
医院药局
- 全球偏头痛治疗药市场，医院药局，各地区(2018年～2030年)
零售药局
- 全球偏头痛治疗药市场，零售药局，各地区(2018年～2030年)
线上药局
- 全球偏头痛治疗药市场，线上药局，各地区(2018年～2030年)

第9章全球偏头痛治疗药市场:各地区

主要调查结果
简介
- 偏头痛治疗药市场评估，各地区(2018年～2030年)
偏头痛治疗药市场 - 北美
- 北美:偏头痛治疗药市场，各产品类型(2018年～2030年)
- 北美:偏头痛治疗药市场，各最终用途(2018年～2030年)
- 北美:偏头痛治疗药市场，各治疗等级(2018年～2030年)
- 北美:偏头痛治疗药市场，各给药途径(2018年～2030年)
- 偏头痛治疗药市场 - 美国
- 偏头痛治疗药市场 - 加拿大
偏头痛治疗药市场 - 欧洲
- 欧洲:偏头痛治疗药市场，各产品类型(2018年～2030年)
- 欧洲:偏头痛治疗药市场，各最终用途(2018年～2030年)
- 欧洲:偏头痛治疗药市场，各治疗等级(2018年～2030年)
- 欧洲:偏头痛治疗药市场，各给药途径(2018年～2030年)
- 偏头痛治疗药市场 - 英国
- 偏头痛治疗药市场 - 法国
- 偏头痛治疗药市场 - 德国
- 偏头痛治疗药市场 - 义大利
- 偏头痛治疗药市场 - 西班牙
- 偏头痛治疗药市场 - 荷兰
- 偏头痛治疗药市场 - 俄罗斯
偏头痛治疗药市场 - 亚太地区
- 亚太地区:偏头痛治疗药市场，各产品类型(2018年～2030年)
- 亚太地区:偏头痛治疗药市场，各最终用途(2018年～2030年)
- 亚太地区:偏头痛治疗药市场，各治疗等级(2018年～2030年)
- 亚太地区:偏头痛治疗药市场，各给药途径(2018年～2030年)
- 偏头痛治疗药市场 - 中国
- 偏头痛治疗药市场 - 印度
- 偏头痛治疗药市场 - 日本
- 偏头痛治疗药市场 - 马来西亚
- 偏头痛治疗药市场 - 印尼
- 偏头痛治疗药市场 - 韩国
偏头痛治疗药市场 - 中东、非洲
- 中东、非洲:偏头痛治疗药市场，各产品类型(2018年～2030年)
- 中东、非洲:偏头痛治疗药市场，各最终用途(2018年～2030年)
- 中东、非洲:偏头痛治疗药市场，各治疗等级(2018年～2030年)
- 中东、非洲:偏头痛治疗药市场，各给药途径(2018年～2030年)
- 偏头痛治疗药市场 - 沙乌地阿拉伯
- 偏头痛治疗药市场 - 南非
- 偏头痛治疗药市场 - 以色列
- 偏头痛治疗药市场 - 阿拉伯联合大公国
偏头痛治疗药市场 - 南美
- 南美:偏头痛治疗药市场，各产品类型，从2018年到2030年
- 南美:偏头痛治疗药市场，各最终用途(2018年～2030年)
- 南美:偏头痛治疗药市场，各治疗等级(2018年～2030年)
- 南美:偏头痛治疗药市场，各给药途径(2018年～2030年)
- 偏头痛治疗药市场 - 墨西哥
- 偏头痛治疗药市场 - 巴西
- 偏头痛治疗药市场 - 阿根廷

第10章竞争情形

扩大、收购的分析
- 扩大
- 收购
伙伴关係/合作/协定/公开

第11章企业简介

Allergan Plc
Alder Biopharmaceuticals Inc.
AstraZeneca PLC
Amgen Inc
eNeura Inc
Endo Pharmaceuticals Inc
Eli Lilly and Company
GlaxoSmithKline Plc
Johnson & Johnson Services Inc
Merck & Co. Inc
Pfizer Inc
Teva Pharmaceutical Industries Ltd

简介目录图表

Product Code: PM1391

The global Migraine Drugs market size is expected to reach USD 8.79 billion by 2030, according to a new study by Polaris Market Research. The report "Migraine Drugs Market Share, Size, Trends, Industry Analysis Report, By Product Type (Acute/Abortive Treatment, Preventive/Prophylactic Treatment); By Therapeutic Class; By Route of Administration; By End-Use; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing prevalence of neurological illnesses such as migraine among the teenage population as a result of a more sedentary lifestyle is expected to boost the market growth in the future years.

For instance, according to the National Institute of Health, Migraine affects about one billion people worldwide each year and is one of the most frequent neurologic illnesses, with a higher incidence and morbidity, especially among young people and females. From 1990 to 2019, the worldwide age-standardized frequency of migraine grew by 1.7%, with 1.1 billion prevalent instances in 2019.

Moreover, the increasing launch of Calcitonin gene-related peptide (CGRP)-based medicines and significant unmet requirements are some of the important reasons driving market expansion. For instance, in December 2019, Ubrelvy (ubrogepant) tablets were approved by the Food and Drug Administration for the acute (immediate) therapy of migraine, either with or without vision in adults.

Ubrelvy is not approved for the prevention of migraines. It is the first medicine licensed for the acute treatment of migraines in the category of oral calcitonin gene-related peptides (CGRP) antagonists. Thus, this rising prevalence, along with the increasing approvals, is driving market growth over the forecast period.

Furthermore, an increase in females number and a rise in patient awareness about migraine prevention and treatment are major drivers driving the market growth. Migraine headaches are more common in women than in men. According to the National Institute of Health of Migraine Association of Ireland, the global population in 2018 had a female migraineur to male migraineur ratio of 3:1. This is due to variations in estrogen levels in females, particularly during menstruation.

Furthermore, hormonal drugs, including oral contraceptives and hormone replacement treatment, may aggravate migraine in women. As a result, an increase in the worldwide female population is expected to drive the market growth of the migraine drugs.

Migraine Drugs Market Report Highlights

Online pharmacy segment is expected to grow at a significant CAGR over the forecast period. It is the quickest segment, offering migraine drugs through e-commerce platforms. The majority of the drugs given by online pharmacy chains are for the treatment of severe migraines.

Preventive/ Prophylactic Treatment segment accounted for a lucrative revenue share. Migraine prevention methods lessen migraine frequency and severity. Beta-blockers, botulism toxin toxins, and topiramate are the main pharmacological types used in preventive therapy.

Asia Pacific is expected to grow at a significant CAGR over the projected period. The Asia Pacific region is expected to grow significantly in the future, due to increased demand for improved health centers and improvements in the healthcare system.

The global players include Allergan, Alder Biopharmaceuticals, AstraZeneca, Amgen Inc., eNeura Inc., Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, and Teva Pharmaceutical.

Polaris Market Research has segmented the migraine drugs market report based on product type, therapeutic class, end-use, route of administration, and region:

Migraine Drugs, Product Type Outlook (Revenue - USD Billion, 2018 - 2030)

Acute / Abortive Treatment

Preventive/ Prophylactic Treatment

Migraine Drugs, Therapeutic Class Outlook (Revenue - USD Billion, 2018 - 2030)

Triptans

Acetylcholine Inhibitors/ neurotoxins

Ergot Alkaloids

NSAIDs

Ditans

CGRP small molecule antagonists

CGRP monoclonal antibodies

Others

Migraine Drugs, Route of Administration Outlook (Revenue - USD Billion, 2018 - 2030)

Oral

Injectables

Others

Migraine Drugs, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

Hospital pharmacies

Retail pharmacies

Online pharmacies

Migraine Drugs, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Migraine Drugs Market Insights

4.1. Migraine Drugs - Industry Snapshot
4.2. Migraine Drugs Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increase in prevalence of migraine
  - 4.2.1.2. Rise in awareness among patients toward migraine treatment and prevention
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Side effects of migraine drug
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Migraine Drugs Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Migraine Drugs Market, by Product Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
5.3. Acute/Abortive Treatment
- 5.3.1. Global Migraine Drugs Market, by Acute/Abortive Treatment, by Region, 2018 - 2030 (USD Billion)
5.4. Preventive/ Prophylactic Treatment
- 5.4.1. Global Migraine Drugs Market, by Preventive/ Prophylactic Treatment, by Region, 2018 - 2030 (USD Billion)

6. Global Migraine Drugs Market, by Therapeutic Class

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
6.3. Triptans
- 6.3.1. Global Migraine Drugs Market, by Triptans, by Region, 2018 - 2030 (USD Billion)
6.4. Acetylcholine Inhibitors/ neurotoxins
- 6.4.1. Global Migraine Drugs Market, by Acetylcholine Inhibitors/ neurotoxins, by Region, 2018 - 2030 (USD Billion)
6.5. Ergot Alkaloids
- 6.5.1. Global Migraine Drugs Market, by Ergot Alkaloids, by Region, 2018 - 2030 (USD Billion)
6.6. NSAIDs
- 6.6.1. Global Migraine Drugs Market, by NSAIDs, by Region, 2018 - 2030 (USD Billion)
6.7. Ditans
- 6.7.1. Global Migraine Drugs Market, by Ditans, by Region, 2018 - 2030 (USD Billion)
6.8. CGRP small molecule antagonists
- 6.8.1. Global Migraine Drugs Market, by CGRP small molecule antagonists, by Region, 2018 - 2030 (USD Billion)
6.9. CGRP monoclonal antibodies
- 6.9.1. Global Migraine Drugs Market, by CGRP monoclonal antibodies, by Region, 2018 - 2030 (USD Billion)
6.10. Others
- 6.10.1. Global Migraine Drugs Market, by Others, by Region, 2018 - 2030 (USD Billion)

7. Global Migraine Drugs Market, by Route of Administration

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
7.3. Oral
- 7.3.1. Global Migraine Drugs Market, by Oral, by Region, 2018 - 2030 (USD Billion)
7.4. Injectables
- 7.4.1. Global Migraine Drugs Market, by Injectables, by Region, 2018 - 2030 (USD Billion)
7.5. Others
- 7.5.1. Global Migraine Drugs Market, by Others, by Region, 2018 - 2030 (USD Billion)

8. Global Migraine Drugs Market, by End-Use

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
8.3. Hospital pharmacies
- 8.3.1. Global Migraine Drugs Market, by Hospital pharmacies, by Region, 2018 - 2030 (USD Billion)
8.4. Retail pharmacies
- 8.4.1. Global Migraine Drugs Market, by Retail pharmacies, by Region, 2018 - 2030 (USD Billion)
8.5. Online pharmacies
- 8.5.1. Global Migraine Drugs Market, by Online pharmacies, by Region, 2018 - 2030 (USD Billion)

9. Global Migraine Drugs Market, by Geography

9.1. Key findings
9.2. Introduction
- 9.2.1. Migraine Drugs Market Assessment, By Geography, 2018 - 2030 (USD Billion)
9.3. Migraine Drugs Market - North America
- 9.3.1. North America: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.3.2. North America: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.3.3. North America: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
- 9.3.4. North America: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.3.5. Migraine Drugs Market - U.S.
  - 9.3.5.1. U.S.: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.3.5.2. U.S.: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.3.5.3. U.S.: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.3.5.4. U.S.: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.3.6. Migraine Drugs Market - Canada
  - 9.3.6.1. Canada: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.3.6.2. Canada: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.3.6.3. Canada: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.3.6.4. Canada: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
9.4. Migraine Drugs Market - Europe
- 9.4.1. Europe: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.4.2. Europe: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.4.3. Europe: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
- 9.4.4. Europe: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.4.5. Migraine Drugs Market - UK
  - 9.4.5.1. UK: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.4.5.2. UK: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.4.5.3. UK: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.4.5.4. UK: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.4.6. Migraine Drugs Market - France
  - 9.4.6.1. France: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.4.6.2. France: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.4.6.3. France: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.4.6.4. France: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.4.7. Migraine Drugs Market - Germany
  - 9.4.7.1. Germany: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.4.7.2. Germany: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.4.7.3. Germany: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.4.7.4. Germany: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.4.8. Migraine Drugs Market - Italy
  - 9.4.8.1. Italy: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.4.8.2. Italy: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.4.8.3. Italy: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.4.8.4. Italy: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.4.9. Migraine Drugs Market - Spain
  - 9.4.9.1. Spain: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.4.9.2. Spain: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.4.9.3. Spain: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.4.9.4. Spain: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.4.10. Migraine Drugs Market - Netherlands
  - 9.4.10.1. Netherlands: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.4.10.2. Netherlands: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.4.10.3. Netherlands: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.4.10.4. Netherlands: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.4.11. Migraine Drugs Market - Russia
  - 9.4.11.1. Russia: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.4.11.2. Russia.: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.4.11.3. Russia: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.4.11.4. Russia: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
9.5. Migraine Drugs Market - Asia Pacific
- 9.5.1. Asia Pacific: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.5.2. Asia Pacific: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.5.3. Asia Pacific: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
- 9.5.4. Asia Pacific: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.5.5. Migraine Drugs Market - China
  - 9.5.5.1. China: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.5.5.2. China.: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.5.5.3. China: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.5.5.4. China: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.5.6. Migraine Drugs Market - India
  - 9.5.6.1. India: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.5.6.2. India.: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.5.6.3. India: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.5.6.4. India: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.5.7. Migraine Drugs Market - Japan
  - 9.5.7.1. Japan: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.5.7.2. Japan.: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.5.7.3. Japan: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.5.7.4. Japan: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.5.8. Migraine Drugs Market - Malaysia
  - 9.5.8.1. Malaysia: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.5.8.2. Malaysia.: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.5.8.3. Malaysia: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.5.8.4. Malaysia: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.5.9. Migraine Drugs Market - Indonesia
  - 9.5.9.1. Indonesia: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.5.9.2. Indonesia.: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.5.9.3. Indonesia: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.5.9.4. Indonesia: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.5.10. Migraine Drugs Market - South Korea
  - 9.5.10.1. South Korea: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.5.10.2. South Korea.: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.5.10.3. South Korea: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.5.10.4. South Korea: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
9.6. Migraine Drugs Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.6.2. Middle East & Africa: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.6.3. Middle East & Africa: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
- 9.6.4. Middle East & Africa: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.6.5. Migraine Drugs Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.6.6. Migraine Drugs Market - South Africa
  - 9.6.6.1. South Africa: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.6.6.2. South Africa: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.6.6.3. South Africa: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.6.6.4. South Africa: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.6.7. Migraine Drugs Market - Israel
  - 9.6.7.1. Israel: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.6.7.2. Israel: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.6.7.3. Israel: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.6.7.4. Israel: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.6.8. Migraine Drugs Market - UAE
  - 9.6.8.1. UAE: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.6.8.2. UAE: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.6.8.3. UAE: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.6.8.4. UAE: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
9.7. Migraine Drugs Market - Latin America
- 9.7.1. Latin America: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
- 9.7.2. Latin America: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
- 9.7.3. Latin America: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
- 9.7.4. Latin America: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.7.5. Migraine Drugs Market - Mexico
  - 9.7.5.1. Mexico: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.7.5.2. Mexico: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.7.5.3. Mexico: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.7.5.4. Mexico: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.7.6. Migraine Drugs Market - Brazil
  - 9.7.6.1. Brazil: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.7.6.2. Brazil: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.7.6.3. Brazil: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.7.6.4. Brazil: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
- 9.7.7. Migraine Drugs Market - Argentina
  - 9.7.7.1. Argentina: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
  - 9.7.7.2. Argentina: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
  - 9.7.7.3. Argentina: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
  - 9.7.7.4. Argentina: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Allergan Plc
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Alder Biopharmaceuticals Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. AstraZeneca PLC
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Amgen Inc
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. eNeura Inc
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Endo Pharmaceuticals Inc
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Eli Lilly and Company
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. GlaxoSmithKline Plc
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Johnson & Johnson Services Inc
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Merck & Co. Inc
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Pfizer Inc
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Teva Pharmaceutical Industries Ltd
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development

简介目录图表

List of Tables

Table 1 Global Migraine Drugs Market, by Product Type, by Region, 2018 - 2030 (USD Billion)
Table 2 Global Migraine Drugs Market, by Therapeutic Class, by Region, 2018 - 2030 (USD Billion)
Table 3 Global Migraine Drugs Market, by Route of Administration, by Region, 2018 - 2030 (USD Billion)
Table 4 Global Migraine Drugs Market, by End-Use, by Region, 2018 - 2030 (USD Billion)
Table 5 Migraine Drugs Market Assessment, By Geography, 2018 - 2030 (USD Billion)
Table 6 North America: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 7 North America: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 8 North America: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 9 North America: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 10 U.S.: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 11 U.S.: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 12 U.S.: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 13 U.S.: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 14 Canada: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 15 Canada: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 16 Canada: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 17 Canada: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 18 Europe: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 19 Europe: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 20 Europe: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 21 Europe: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 22 Germany: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 23 Germany: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 24 Germany: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 25 Germany: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 26 France: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 27 France: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 28 France: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 29 France: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 30 UK: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 31 UK: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 32 UK: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 33 UK: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 34 Italy: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 35 Italy: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 36 Italy: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 37 Italy: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 38 Netherlands: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 39 Netherlands: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 40 Netherlands: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 41 Netherlands: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 42 Spain: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 43 Spain: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 44 Spain: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 45 Spain: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 46 Russia: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 47 Russia: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 48 Russia: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 49 Russia: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 50 Asia Pacific: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 51 Asia Pacific: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 52 Asia Pacific: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 53 Asia Pacific: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 54 China: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 55 China: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 56 China: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 57 China: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 58 Japan: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 59 Japan: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 60 Japan: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 61 Japan: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 62 India: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 63 India: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 64 India: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 65 India: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 66 Indonesia: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 67 Indonesia: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 68 Indonesia: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 69 Indonesia: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 70 Malaysia: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 71 Malaysia: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 72 Malaysia: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 73 Malaysia: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 74 South Korea: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 75 South Korea: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 76 South Korea: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 77 South Korea: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 78 Latin America: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 79 Latin America: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 80 Latin America: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 81 Latin America: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 82 Brazil: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 83 Brazil: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 84 Brazil: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 85 Brazil: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 86 Mexico: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 87 Mexico: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 88 Mexico: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 89 Mexico: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 90 Argentina: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 91 Argentina: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 92 Argentina: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 93 Argentina: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 94 Middle East & Africa: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 95 Middle East & Africa: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 96 Middle East & Africa: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 97 Middle East & Africa: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 98 UAE: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 99 UAE: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 100 UAE: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 101 UAE: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 102 Saudi Arabia: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 103 Saudi Arabia: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 104 Saudi Arabia: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 105 Saudi Arabia: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 106 South Africa: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 107 South Africa: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 108 South Africa: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 109 South Africa: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)
Table 110 Israel: Migraine Drugs Market, by Product Type, 2018 - 2030 (USD Billion)
Table 111 Israel: Migraine Drugs Market, by Therapeutic Class, 2018 - 2030 (USD Billion)
Table 112 Israel: Migraine Drugs Market, by Route of Administration, 2018 - 2030 (USD Billion)
Table 113 Israel: Migraine Drugs Market, by End-Use, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Migraine Drugs Market, 2018 - 2030 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up End-Use

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Product Type

Figure 7. Global Migraine Drugs Market, by Product Type, 2021 & 2030 (USD Billion)

Figure 8. Market by End-Use

Figure 9. Global Migraine Drugs Market, by End-Use, 2021 & 2030 (USD Billion)

Figure 10. Market by Therapeutic Class

Figure 11. Global Migraine Drugs Market, by Therapeutic Class, 2021 & 2030 (USD Billion)

Figure 12. Market by Route of Administration

Figure 13. Global Migraine Drugs Market, by Route of Administration, 2021 & 2030 (USD Billion)

Figure 14. Migraine Drugs Market Assessment, By Geography, 2018 - 2030 (USD Billion)

Figure 15. Strategic Analysis - Migraine Drugs Market

02-2729-4219

+886-2-2729-4219

License/价格

偏头痛治疗药的全球市场 - 市场占有率、规模、趋势、产业分析:各产品类型，各治疗等级，各给药途径，各最终用途，各地区，市场区隔预测(2022年～2030年)

Migraine Drugs Market Share, Size, Trends, Industry Analysis Report, By Product Type (Acute/Abortive Treatment, Preventive/Prophylactic Treatment); By Therapeutic Class; By Route of Administration; By End-Use; By Region; Segment Forecast, 2022 - 2030